China Cell and Gene Therapy Manufacturing QC Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, Gene Therapy), By Scale (Pre-commercial/ R&D Manufacturing, Commercial Scale Manufacturing), By Mode (Contract Manufacturing, In-house Manufacturing), By Workflow (Cell Processing, Cell Banking, Fill & Finish Operations, Raw Material Testing, Vector Production, Other Workflows), By Process (Upstream Processes, Downstream Processes), By End-User (Pharmaceutical Companies, Biopharmaceutical / Biotechnological Companies, Contract Manufacturing Organizations), By Technology Type (Fluorescence-Activated Cell Sorting (FACS), Enzyme-Linked Immunosorbent Assay (ELISA), Chromatography, Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Others) and Forecasts, 2026-2034

Last Updated: July 08, 2026 | Author: Debashree B | Format: | Report Code: SR6218DR | Pages: 80

Market Segmentation

  1. China Cell and Gene Therapy Manufacturing QC Market, By Therapy Type 2022 (USD MILLION/ Units)
    1. Cell Therapy
      1. CAR-T
        1. Autologous CAR-T
        2. Allogeneic CAR-T
      2. CAR-NK
      3. B-Cell
      4. Others
    2. Gene Therapy
      1. Viral
        1. AAV
        2. Lentiviral vectors
        3. Other
      2. Non-Viral
  2. China Cell and Gene Therapy Manufacturing QC Market, By Scale 2022 (USD MILLION/ Units)
    1. Pre-commercial/ R&D Manufacturing
    2. Commercial Scale Manufacturing
  3. China Cell and Gene Therapy Manufacturing QC Market, By Mode 2022 (USD MILLION/ Units)
    1. Contract Manufacturing
    2. In-house Manufacturing
  4. China Cell and Gene Therapy Manufacturing QC Market, By Workflow 2022 (USD MILLION/ Units)
    1. Cell Processing
    2. Cell Banking
    3. Fill & Finish Operations
    4. Raw Material Testing
    5. Vector Production
    6. Other Workflows
  5. China Cell and Gene Therapy Manufacturing QC Market, By Process 2022 (USD MILLION/ Units)
    1. Upstream Processes
    2. Downstream Processes
  6. China Cell and Gene Therapy Manufacturing QC Market, By End-User 2022 (USD MILLION/ Units)
    1. Pharmaceutical Companies
      1. Small Size
      2. Medium Size
      3. Large Size
    2. Biopharmaceutical / Biotechnological Companies
      1. Small Size
      2. Medium Size
      3. Large Size
    3. Contract Manufacturing Organizations
      1. Small Size
      2. Medium Size
      3. Large Size
  7. China Cell and Gene Therapy Manufacturing QC Market, By Technology Type 2022 (USD MILLION/ Units)
    1. Fluorescence-Activated Cell Sorting (FACS)
    2. Enzyme-Linked Immunosorbent Assay (ELISA)
    3. Chromatography
    4. Next-Generation Sequencing (NGS)
    5. Polymerase Chain Reaction (PCR)
    6. Others
  8. Regional China Cell and Gene Therapy Manufacturing QC Market
    1. China
      1. China China Cell and Gene Therapy Manufacturing QC Market By Therapy Type 2022 (USD MILLION/ Units)
        1. Cell Therapy
          1. CAR-T
            1. Autologous CAR-T
            2. Allogeneic CAR-T
          2. CAR-NK
          3. B-Cell
          4. Others
        2. Gene Therapy
          1. Viral
            1. AAV
            2. Lentiviral vectors
            3. Other
          2. Non-Viral
      2. China China Cell and Gene Therapy Manufacturing QC Market By Scale 2022 (USD MILLION/ Units)
        1. Pre-commercial/ R&D Manufacturing
        2. Commercial Scale Manufacturing
      3. China China Cell and Gene Therapy Manufacturing QC Market By Mode 2022 (USD MILLION/ Units)
        1. Contract Manufacturing
        2. In-house Manufacturing
      4. China China Cell and Gene Therapy Manufacturing QC Market By Workflow 2022 (USD MILLION/ Units)
        1. Cell Processing
        2. Cell Banking
        3. Fill & Finish Operations
        4. Raw Material Testing
        5. Vector Production
        6. Other Workflows
      5. China China Cell and Gene Therapy Manufacturing QC Market By Process 2022 (USD MILLION/ Units)
        1. Upstream Processes
        2. Downstream Processes
      6. China China Cell and Gene Therapy Manufacturing QC Market By End-User 2022 (USD MILLION/ Units)
        1. Pharmaceutical Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        2. Biopharmaceutical / Biotechnological Companies
          1. Small Size
          2. Medium Size
          3. Large Size
        3. Contract Manufacturing Organizations
          1. Small Size
          2. Medium Size
          3. Large Size
      7. China China Cell and Gene Therapy Manufacturing QC Market By Technology Type 2022 (USD MILLION/ Units)
        1. Fluorescence-Activated Cell Sorting (FACS)
        2. Enzyme-Linked Immunosorbent Assay (ELISA)
        3. Chromatography
        4. Next-Generation Sequencing (NGS)
        5. Polymerase Chain Reaction (PCR)
        6. Others
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: